Coronary interventions - Mini focus on bioresorbable scaffolds

Preclinical investigation of neoatherosclerosis in magnesium-based bioresorbable scaffolds versus thick-strut drug-eluting stents

EuroIntervention 2020;16:e922-e929. DOI: 10.4244/EIJ-D-19-00747

Philipp Nicol
Philipp Nicol1, MD; Anna Bulin1, MD, DVM; Maria Isabel Castellanos1,2, PhD; Magdalena Stöger1, MS; Simone Obermeier1, MS; Jonas Lewerich1, MS; Tobias Lenz1, MD; Petra Hoppmann2,3, MD; Christine Baumgartner4, DVM; Johannes Fischer4, DVM; Katja Steiger5, DVM; Michael Haude6, MD; Michael Joner1,2, MD
1. Deutsches Herzzentrum München and Deutsches Zentrum für Herz-Kreislaufforschung e.V., Munich, Germany; 2. DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany; 3. Klinik und Poliklinik für Innere Medizin I, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; 4. Zentrum für präklinische Forschung, Technische Universität München, Munich, Germany; 5. Institut für Pathologie, Technische Universität München, Munich, Germany; 6. Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany

Aims: Neoatherosclerosis is a frequent finding after implantation of permanent metallic stents. Bioresorbable scaffolds (BRS) are considered to reduce the incidence of neoatherosclerosis owing to their dissolution and consequent vascular restoration. The aim of this study was to evaluate the formation of neoatherosclerosis between magnesium-based BRS and thick-strut metallic drug-eluting stents (DES) in a rabbit model of neoatherosclerosis and in proportion to the effect of high-dose statin medication.

Methods and results: Fully bioresorbable magnesium scaffolds (BRS, n=45) and thick-strut permanent metallic DES of equivalent geometry and design (n=45) were implanted into the iliac arteries of New Zealand White rabbits (n=45) following endothelial balloon injury and exposure to a cholesterol diet. Endothelialisation was assessed in 12 animals after 35 days using scanning electron microscopy (SEM), showing significantly enhanced re-endothelialisation above struts in the BRS (n=13) compared to DES (n=10). Eleven (11) animals were terminated for baseline assessment after 91 days while the remaining 22 animals were randomised to receive high-dose statin treatment (3 mg/kg) or placebo. BRS-treated vessels showed a significant reduction in foam cell infiltration as a sign of early neoatherosclerosis by histology and OCT when compared to thick-strut DES-treated vessels. Statin treatment resulted in significant reduction of foam cell infiltration in BRS and DES by histology.

Conclusions: Our findings suggest reduced neoatherosclerosis formation in magnesium-based BRS relative to thick-strut DES. High-dose statin treatment may be a promising measure to reduce neoatherosclerosis progression, both on its own and in synergy with site-targeted device-based treatment.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bioresorbable scaffoldsdrug-eluting stentoptical coherence tomography
Coronary interventionsStents and scaffolds
Read next article
Impact of bioresorbable scaffold design characteristics on local haemodynamic forces: an ex vivo assessment with computational fluid dynamics simulations

Latest news